Herziger, Birthe
Jeschke, Sarah
Müller, Ruth Melinda
Neininger, Martina Patrizia
Bertsche, Thilo
Bertsche, Astrid
Funding for this research was provided by:
Universitätsmedizin Rostock
Article History
Received: 28 June 2021
Revised: 14 January 2022
Accepted: 10 February 2022
First Online: 23 February 2022
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. The study described has been carried out in accordance with the abovementioned standards and has been approved by the Ethics Committee of Medical Faculty of Rostock University, Germany (Ethics approval number: A 2019–0036).
: Written informed consent was obtained from all individual participants included in the study.
: Not applicable.
: AB reports grants from UCB Pharma GmbH and honoraria for speaking engagements from Biogen GmbH, Desitin Arzneimittel GmbH, Eisai GmbH, GW Pharma GmbH, Neuraxpharm GmbH, Shire/Takeda GmbH, UCB Pharma GmbH, and ViroPharma GmbH. The other authors declare no competing interests.